Structural basis for membrane anchoring of HIV-1 envelope spike

Science

Volumn 353, Issue 6295, 2016, Pages 172-175

  Dev, Jyoti ^a   Park, Donghyun ^b   Fu, Qingshan ^a   Chen, Jia ^a,b   Ha, Heather Jiwon ^a,b   Ghantous, Fadi ^c   Herrmann, Tobias ^a   Chang, Weiting ^b   Liu, Zhijun ^d   Frey, Gary ^a,b   Seaman, Michael S ^c   Chen, Bing ^a,b   Chou, James J ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LIPID; MEMBRANE PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LIPID BILAYER;

ANTIBODY; GENE; HUMAN IMMUNODEFICIENCY VIRUS; LIPID; MEMBRANE; NUCLEAR MAGNETIC RESONANCE; PROTEIN; VIRUS;

ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILICITY; HYDROPHOBICITY; LIPID BILAYER; MEMBRANE FUSION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STABILITY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS STRAIN; CHEMISTRY; GENETICS; IMMUNOLOGY; MUTATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; VIRUS ENTRY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ARGININE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; LIPID BILAYERS; MEMBRANE FUSION; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; VIRUS INTERNALIZATION;

EID: 84976908417     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf7066     Document Type: Article

References (32)

1. S. C. Harrison, Nat. Struct. Mol. Biol. 15, 690-698 (2008).
2. D. C. Chan, D. Fass, J. M. Berger, P. S. Kim, Cell 89, 263-273 (1997).
3. W. Weissenhorn, A. Dessen, S. C. Harrison, J. J. Skehel, D. C. Wiley, Nature 387, 426-430 (1997).
4. M. Pancera et al., Nature 514, 455-461 (2014).
5. X. Wei et al., Nature 422, 307-312 (2003).
6. D. D. Richman, T. Wrin, S. J. Little, C. J. Petropoulos, Proc. Natl. Acad. Sci. U.S.A. 100, 4144-4149 (2003).
7. J. H. Lee, G. Ozorowski, A. B. Ward, Science 351, 1043-1048 (2016).
8. R. J. Owens, C. Burke, J. K. Rose, J. Virol. 68, 570-574 (1994).
9. L. Shang, L. Yue, E. Hunter, J. Virol. 82, 5417-5428 (2008).
10. L. Yue, L. Shang, E. Hunter, J. Virol. 83, 11588-11598 (2009).
11. E. Helseth et al., J. Virol. 64, 6314-6318 (1990).
12. M. G. Teese, D. Langosch, Biochemistry 54, 5125-5135 (2015).
13. J. Chen et al., Science 349, 191-195 (2015).
14. F. Gao et al., J. Virol. 70, 1651-1667 (1996).
15. J. F. Rowell, P. E. Stanhope, R. F. Siliciano, J. Immunol. 155,473-488 (1995).
16. M. Boge, S. Wyss, J. S. Bonifacino, M. Thali, J. Biol. Chem. 273,15773-15778 (1998).
17. M. E. Call et al., Cell 127, 355-368 (2006).
18. M. E. Call, K. W. Wucherpfennig, J. J. Chou, Nat. Immunol. 11, 1023-1029 (2010).
19. K. J. Glover et al., Biophys. J. 81, 2163-2171 (2001).
20. C. R. Sanders 2nd, J. P. Schwonek, Biochemistry 31, 8898-8905 (1992).
21. B. OuYang et al., Nature 498, 521-525 (2013).
22. P. Zhu et al., Nature 441, 847-852 (2006).
23. R. W. Sanders et al., PLOS Pathog. 9, e1003618 (2013).
24. J. P. Julien et al., Proc. Natl. Acad. Sci. U.S.A. 110, 4351-4356 (2013).
25. J. T. West, P. B. Johnston, S. R. Dubay, E. Hunter, J. Virol. 75, 9601-9612 (2001).
26. J. Chen et al., J. Virol. 88, 1249-1258 (2014).
27. C. Berlioz-Torrent et al., J. Virol. 73, 1350-1361 (1999).
28. S. A. Jeffs et al., Vaccine 22, 1032-1046 (2004).
29. J.M. Kovacs et al.,Proc. Natl. Acad. Sci. U.S.A. 111, 18542-18547 (2014).
30. J. Guenaga et al., J. Virol. 90, 2806-2817 (2015).
31. Y. Do Kwon et al., Nat. Struct. Mol. Biol. 22, 522-531 (2015).
32. M. C. Wiener, S. H. White, Biophys. J. 61, 434-447 (1992).